Israel Englander’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Israel Englander’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-919,300	Closed	-$106M	–	6870
2023 Q3	$106M	Sell	919,300 -160,200	-15%	-$17.2M	0.05%	349
2023 Q2	$111M	Buy	1,079,500 +604,100	+127%	+$63.7M	0.05%	317
2023 Q1	$51.9M	Buy	475,400 +458,300	+2,680%	+$50.7M	0.03%	669
2022 Q4	$1.95M	Buy	+17,100	New	+$1.42M	﹤0.01%	3595
2021 Q2	–	Sell	-2,600	Closed	-$239K	–	7490
2021 Q1	$239K	Buy	+2,600	New	+$219K	﹤0.01%	5390
2020 Q2	–	Sell	-50,000	Closed	-$1.48M	–	4877
2020 Q1	$1.48M	Buy	+50,000	New	+$1.69M	﹤0.01%	2226
2019 Q2	–	Sell	-100,000	Closed	-$2.64M	–	4753
2019 Q1	$2.64M	Buy	100,000 +75,000	+300%	+$1.78M	﹤0.01%	2219
2018 Q4	$489K	Hold	25,000	–	–	﹤0.01%	2986
2018 Q3	$490K	Buy	+25,000	New	+$475K	﹤0.01%	3272
2017 Q1	–	Sell	-60,500	Closed	-$979K	–	4026
2016 Q4	$979K	Buy	60,500 +33,500	+124%	+$607K	﹤0.01%	2261
2016 Q3	$490K	Buy	+27,000	New	+$528K	﹤0.01%	2616

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Israel Englander's HZNP Position: Q4 2023 in Review

Israel Englander sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,588,563 shares — an estimated $531M sold.

Israel Englander first reported a position in HZNP in Q2 2013 and held it in 38 quarters. The position peaked at $531M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Israel Englander reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Israel Englander sold 4,588,563 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $531M.
Israel Englander first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 38 quarters.
Israel Englander's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $531M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.